Name
MTP I: AML
Date & Time
Wednesday, September 3, 2025, 7:00 AM - 7:45 AM
Description
MTP Session I: AML
Session Chair: Tapan Kadia, MD
- Future Role of CPX-351 and CPX-351-Based Combinations | Jeffrey Lancet, MD | H. Lee Moffitt Cancer Center, Tampa, Florida, USA
- Role of Intensive Chemotherapy Plus Venetoclax | Tapan Kadia, MD | MD Anderson Cancer Center, Houston, Texas, USA
- How to Select Intensive vs. Lower Intensity Therapy in Younger Patients | Amir Fathi, MD | Massachusetts General Hospital, Boston, Massachusetts, USA
Speakers
Amir Fathi, Massachusetts General Hospital
Tapan Kadia, MD Anderson Cancer Center
Jeffrey Lancet, H. Lee Moffitt Cancer Center
Tapan Kadia, MD Anderson Cancer Center
Jeffrey Lancet, H. Lee Moffitt Cancer Center
Location Name
GRB Level 3, Room 361BCEF
Virtual Session Link